Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-03-02 @ 8:18 AM
Study NCT ID:
NCT03214250
Status:
COMPLETED
Last Update Posted:
2022-12-23
First Post:
2017-06-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
Sponsor:
Parker Institute for Cancer Immunotherapy
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-25
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-09
First Submit QC Date:
None
Study First Post Date:
2017-07-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-03-25
Results First Submit QC Date:
None
Results First Post Date:
2022-08-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-21
Last Update Post Date:
2022-12-23
Last Update Post Date Type:
ACTUAL